Breast Cancer Patient-Derived Organoids for the Investigation of Patient-Specific Tumour Evolution

A reliable preclinical model of patient-derived organoids was developed in a case study of a 69-year-old woman diagnosed with breast cancer to investigate the tumour evolution before and after neoadjuvant chemotherapy and surgery.